Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about BIRC5: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
BIRC5 is a gene implicated in neurodegeneration research. Key relationships include: therapeutic target, associated with, implicated in. Associated with Als, Cancer, Carcinoma. Connected to 48 entities in the SciDEX knowledge graph.
| Gene Symbol | BIRC5 |
| Full Name | Survivin (Baculoviral IAP Repeat-Containing Protein 5) |
| Aliases | Survivin |
| Chromosome | 17q25.3. |
| Primary Expression | cancer cells, survivin has since been recognized for its dual functions in both mitotic regulation and apoptosis inhibition [@ambrosini1997] |
| Molecular Weight | 16.5 kDa |
| Amino Acids | 142 aa |
| UniProt ID | [O15392](https://www.uniprot.org/uniprot/O15392) |
| Ensembl ID | ENSG00000089685 |
| OMIM | 603352 |
| GeneCards | BIRC5 |
| Human Protein Atlas | BIRC5 |
| Associated Diseases | Carcinoma, Hepatocellular Carcinoma, Ms |
| Interactions | CANCER |
| KG Connections | 65 knowledge graph edges |
| Databases | GeneCardsNCBI GeneHPASTRING |
Knowledge base pages for this entity
graph TD
BIRC5["<b>BIRC5</b>"]
Als{"Als"}
BIRC5 -->|"therapeutic target"| Als
Cancer{"Cancer"}
BIRC5 -->|"therapeutic target"| Cancer
Tumor{"Tumor"}
BIRC5 -->|"therapeutic target"| Tumor
Ms{"Ms"}
BIRC5 -->|"associated with"| Ms
Carcinoma{"Carcinoma"}
BIRC5 -->|"associated with"| Carcinoma
CANCER["CANCER"]
BIRC5 -->|"therapeutic target"| CANCER
MDM2["MDM2"]
BIRC5 -->|"therapeutic target"| MDM2
Akt(["Akt"])
BIRC5 -->|"therapeutic target"| Akt
Mtor(["Mtor"])
BIRC5 -->|"therapeutic target"| Mtor
Epigenetic(["Epigenetic"])
BIRC5 -->|"therapeutic target"| Epigenetic
Mapk(["Mapk"])
BIRC5 -->|"therapeutic target"| Mapk
Pi3K(["Pi3K"])
BIRC5 -->|"therapeutic target"| Pi3K
MTOR["MTOR"]
MTOR -->|"therapeutic target"| BIRC5
PHOX2B["PHOX2B"]
PHOX2B -->|"therapeutic target"| BIRC5
PI3K["PI3K"]
PI3K -->|"therapeutic target"| BIRC5
AKT["AKT"]
AKT -->|"therapeutic target"| BIRC5
IL6["IL6"]
IL6 -->|"therapeutic target"| BIRC5
PER["PER"]
PER -->|"associated with"| BIRC5
MYC["MYC"]
MYC -->|"therapeutic target"| BIRC5
style BIRC5 fill:#1a3a4a,stroke:#4fc3f7,stroke-width:3px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| Cancer | therapeutic_target | disease | 0.75 |
| CANCER | therapeutic_target | gene | 0.70 |
| Mapk | therapeutic_target | pathway | 0.70 |
| Als | therapeutic_target | disease | 0.65 |
| Tumor | therapeutic_target | disease | 0.65 |
| Ms | associated_with | disease | 0.65 |
| Carcinoma | associated_with | disease | 0.65 |
| Hepatocellular Carcinoma | associated_with | disease | 0.65 |
| Neuroblastoma | therapeutic_target | disease | 0.65 |
| Cancer | activates | disease | 0.65 |
| Carcinoma | activates | disease | 0.65 |
| MDM2 | therapeutic_target | gene | 0.60 |
| PTEN | therapeutic_target | gene | 0.60 |
| IL6 | therapeutic_target | gene | 0.60 |
| MYC | therapeutic_target | gene | 0.60 |
| PI3K | therapeutic_target | gene | 0.60 |
| PHOX2B | therapeutic_target | gene | 0.60 |
| AKT | therapeutic_target | gene | 0.60 |
| OVERVIEW | therapeutic_target | gene | 0.60 |
| MTOR | therapeutic_target | gene | 0.60 |
| RAF1 | therapeutic_target | gene | 0.60 |
| MAPK3 | therapeutic_target | gene | 0.60 |
| MAPK1 | therapeutic_target | gene | 0.60 |
| PRKCD | therapeutic_target | gene | 0.60 |
| CDKN1A | therapeutic_target | gene | 0.60 |
| CDKN1B | therapeutic_target | gene | 0.60 |
| CTSB | therapeutic_target | gene | 0.60 |
| VIM | associated_with | gene | 0.60 |
| NR3C1 | associated_with | gene | 0.60 |
| FOXO6 | associated_with | gene | 0.60 |
| Akt | therapeutic_target | pathway | 0.60 |
| Mtor | therapeutic_target | pathway | 0.60 |
| Epigenetic | therapeutic_target | pathway | 0.60 |
| Pi3K | therapeutic_target | pathway | 0.60 |
| GENES | associated_with | gene | 0.60 |
| PER | associated_with | gene | 0.60 |
| DNA | associated_with | gene | 0.60 |
| Cell Cycle | associated_with | pathway | 0.60 |
| Dna Repair | associated_with | pathway | 0.60 |
| RAS | therapeutic_target | gene | 0.60 |
| Pi3K/Akt | therapeutic_target | pathway | 0.60 |
| GENES | therapeutic_target | gene | 0.60 |
| AUTOPHAGY | therapeutic_target | gene | 0.60 |
| Autophagy | therapeutic_target | pathway | 0.60 |
| T Cell | therapeutic_target | cell_type | 0.60 |
| CANCER | activates | gene | 0.60 |
| T Cell | expressed_in | cell_type | 0.55 |
| CXCL8 | associated_with | gene | 0.50 |
| DNMT1 | associated_with | protein | 0.50 |
| Chemoresistance | associated_with | pathway | 0.50 |
| Source | Relation | Type | Str |
|---|---|---|---|
| MTOR | therapeutic_target | gene | 0.60 |
| PHOX2B | therapeutic_target | gene | 0.60 |
| PI3K | therapeutic_target | gene | 0.60 |
| AKT | therapeutic_target | gene | 0.60 |
| IL6 | therapeutic_target | gene | 0.60 |
| MYC | therapeutic_target | gene | 0.60 |
| PTEN | therapeutic_target | gene | 0.60 |
| CXCL8 | associated_with | gene | 0.60 |
| DNMT1 | associated_with | gene | 0.60 |
| FOXO6 | associated_with | gene | 0.60 |
| NR3C1 | associated_with | gene | 0.60 |
| VIM | associated_with | gene | 0.60 |
| PER | associated_with | gene | 0.60 |
| GENES | associated_with | gene | 0.60 |
| AND | associated_with | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||